| abstract |
Compounds of formula (I), and pharmaceutically acceptable salts and in vivo hydrolysable esters: [Chemical 1] (Wherein R 1 , R 2 , R 3 , R 4 , R 5 and p are as described). Also described are their production methods and their use as pharmaceuticals (especially pharmaceuticals for the expression of cell cycle inhibition (anti-cell proliferation) effects in warm-blooded animals such as humans). |